Neuro-Oncology Reviews

Volume 24 Number 23
15 December 2022

Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 23, 15 December

Bauman MMJ, Bouchal SM, Monie DD, Aibaidula A, Singh R, Parney IF.
Strategies, considerations, and recent advancements in the development of liquid biopsy for glioblastoma: a step towards individualized medicine in glioblastoma.
Neurosurg Focus. 2022 Dec;53(6):E14→. doi: 10.3171/2022.9.FOCUS22430→. PMID: 36455271→. Review. ˍ

Gajjar A, Mahajan A, Abdelbaki M, Anderson C, Antony R, Bale T, Bindra R, Bowers DC, Cohen K, Cole B, Dorris K, Ermoian R, Franson A, Helgager J, Landi D, Lin C, Metrock L, Nanda R, Palmer J, Partap S, Plant A, Pruthi S, Reynolds R, Ruggieri P, Stearns D, Storm P, Wang A, Warren K, Whipple N, Zaky W, McMillian NR, Pluchino LA.
Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw. 2022 Dec;20(12):1339-1362→. doi: 10.6004/jnccn.2022.0062(?). PMID: 36509072→. Guidelines. ˍ

Schlürmann T, Waschulzik B, Combs S, Gempt J, Wiestler B, Weber W, Yakushev I.
Diagnostic utility of amino acid PET in the differential diagnosis of recurrent brain metastases and treatment-related changes: a meta-analysis.
J Nucl Med. 2022 Dec 2:jnumed.122.264803→. doi: 10.2967/jnumed.122.264803→. PMID: 36460343→. Meta-analysis˰ ˍ

Ghimire P, Pang G, Philip J, Hazem S, Rajwani K, Lavrador JP, Grahovac G, Bleil C, Thomas N, Gullan R, Vergani F, Bhangoo R, Ashkan K.
Therapeutic strategies and challenges in the management of craniospinal tumours in pregnancy: a 10-year retrospective tertiary centre study, systematic review, and proposal of treatment algorithms.
World Neurosurg. 2022 Dec 5:S1878-8750(22)01691-6→. doi: 10.1016/j.wneu.2022.11.139→. PMID: 36481447→. Observational study, Review˰ ˍ

Voronova V, Vislobokova A, Mutig K, Samsonov M, Peskov K, Sekacheva M, Materenchuk M, Bunyatyan N, Lebedeva S.
Combination of immune checkpoint inhibitors with radiation therapy in cancer: A hammer breaking the wall of resistance.
Front Oncol. 2022 Dec 5;12:1035884→. doi: 10.3389/fonc.2022.1035884→. PMID: 36544712→. Review. ˍ

Bex A, Mathon B.
Advances, technological innovations, and future prospects in stereotactic brain biopsies.
Neurosurg Rev. 2022 Dec 6, 2023;46(1):5→. doi: 10.1007/s10143-022-01918-w→. PMID: 36471144→. Review. ˍ

Eisler L, Jackson WM, Sun LS, Sands SA.
Impact of Anesthetic Exposures on the Neurocognitive Profiles of Pediatric Brain Tumor Survivors: A New Direction for Research and Multidisciplinary Collaboration.
J Neurosurg Anesthesiol. 2022 Dec 6, 2023;35(1):133-135→. doi: 10.1097/ANA.0000000000000882→. PMID: 36745177→. Review. ˍ

Galli R, Juratli TA, Uckermann O.
Clinical Raman spectroscopy of brain tumors from an interdisciplinary perspective.
Clin Neuropathol. 2022 Dec 6→. doi: 10.5414/NP301522→. PMID: 36472392→. Review˰ ˍ

Montella L, Cuomo M, Del Gaudio N, Buonaiuto M, Costabile D, Visconti R, Di Risi T, Vinciguerra R, Trio F, Ferraro S, Bove G, Facchini G, Altucci L, Chiariotti L, Della Monica R.
Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance.
Int J Cancer. 2022 Dec 7→. doi: 10.1002/ijc.34381→. PMID: 36479695→. Review˰ ˍ

Ranjbarzadeh R, Caputo A, Tirkolaee EB, Jafarzadeh Ghoushchi S, Bendechache M.
Brain tumor segmentation of MRI images: A comprehensive review on the application of artificial intelligence tools.
Comput Biol Med. 2022 Dec 7, 2023;152:106405→. doi: 10.1016/j.compbiomed.2022.106405→. PMID: 36512875→. Review˰ ˍ

Cao L, Zhang M, Zhang Y, Ji B, Wang X, Wang X.
Progress of radiological-pathological workflows in the differential diagnosis between primary central nervous system lymphoma and high-grade glioma (Review).
Oncol Rep. 2022 Dec 8, 2023;49(1):20→. doi: 10.3892/or.2022.8457→. PMID: 36484403→. Review. ˍ

Latini F, Jakola A, Rudà R.
Editorial: Investigating the gliomas/white matter interplay and its implications for multidisciplinary treatment: State of art and future perspectives.
Front Neurosci. 2022 Dec 8;16:1100972→. doi: 10.3389/fnins.2022.1100972→. PMID: 36570851→. Topic introduction. ˍ

Liu YY, Yao RQ, Long LY, Liu YX, Tao BY, Liu HY, Liu JL, Li Z, Chen L, Yao YM.
Worldwide productivity and research trend of publications concerning glioma-associated macrophage/microglia: A bibliometric study.
Front Neurol. 2022 Dec 8;13:1047162→. doi: 10.3389/fneur.2022.1047162→. PMID: 36570441→. Bibliometric analysis. ˍ

Gatto L, Franceschi E, Tosoni A, Di Nunno V, Tonon C, Lodi R, Agati R, Bartolini S, Brandes AA.
Beyond Imaging and Genetic Signature in Glioblastoma: Radiogenomic Holistic Approach in Neuro-Oncology.
Biomedicines. 2022 Dec 9;10(12):3205→. doi: 10.3390/biomedicines10123205→. PMID: 36551961→. Review. ˍ

Cooney T, Lindsay H, Leary S, Wechsler-Reya R.
Current studies and future directions for medulloblastoma: A review from the pacific pediatric neuro-oncology consortium (PNOC) disease working group.
Neoplasia. 2022 Dec 11, 2023;35:100861→. doi: 10.1016/j.neo.2022.100861→. PMID: 36516489→. Meeting report. ˍ

Singnurkar A, Poon R, Detsky J.
18F-FET-PET imaging in high-grade gliomas and brain metastases: a systematic review and meta-analysis.
J Neurooncol. 2022 Dec 11→. doi: 10.1007/s11060-022-04201-6→. PMID: 36502457→. Review, Meta-analysis˰ ˍ

Karabacak M, Ozkara BB, Ozturk A, Kaya B, Cirak Z, Orak E, Ozcan Z.
Radiomics-based machine learning models for prediction of medulloblastoma subgroups: a systematic review and meta-analysis of the diagnostic test performance.
Acta Radiol. 2022 Dec 12:2841851221143496→. doi: 10.1177/02841851221143496→. PMID: 36510435→. Review, Meta-analysis˰ ˍ

Varela ML, Comba A, Faisal SM, Argento A, Franson A, Barissi MN, Sachdev S, Castro MG, Lowenstein PR.
Gene therapy for high grade glioma: the clinical experience.
Expert Opin Biol Ther. 2022 Dec 13→. doi: 10.1080/14712598.2022.2157718→. PMID: 36510843→. Review˰ ˍ

Bezawork-Geleta A, Dimou J, Watt MJ.
Lipid droplets and ferroptosis as new players in brain cancer glioblastoma progression and therapeutic resistance.
Front Oncol. 2022 Dec 15;12:1085034→. doi: 10.3389/fonc.2022.1085034→. PMID: 36591531→. Review. ˍ

Das S, Mishra RK, Agrawal A.
Prognostic factors affecting outcome of multifocal or multicentric glioblastoma: A scoping review.
J Neurosci Rural Pract. 2022 Dec 15, 2023;14(2):199-209→. doi: 10.25259/JNRP_41_2022→. PMID: 37181186→. Review. ˍ

El Atat O, Naser R, Abdelkhalek M, Habib RA, El Sibai M.
Molecular targeted therapy: A new avenue in glioblastoma treatment.
Oncol Lett. 2022 Dec 15;25(2):46→. doi: 10.3892/ol.2022.13632→. PMID: 36644133→. Review. ˍ

Funakoshi Y, Sugihara Y, Uneda A, Nakashima T, Suzuki H.
Recent advances in the molecular understanding of medulloblastoma.
Cancer Sci. 2022 Dec 15→. doi: 10.1111/cas.15691→. PMID: 36520034→. Review. ˍ

Jaju A, Li Y, Dahmoush H, Gottardo NG, Laughlin S, Mirsky D, Panigrahy A, Sabin ND, Shaw D, Storm PB, Poussaint TY, Patay Z, Bhatia A.
Imaging of pediatric brain tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee/ASPNR White Paper.
Pediatr Blood Cancer. 2022 Dec 15:e30147→. doi: 10.1002/pbc.30147→. PMID: 36519599→. Guidelines˰ ˍ

Jusue-Torres I, Lee J, Germanwala AV, Burns TC, Parney IF.
Impact of extent of resection on survival on Glioblastoma, IDH-wildtype, WHO grade 4 (WHO 2021). Systematic review and meta-analysis.
World Neurosurg. 2022 Dec 15:S1878-8750(22)01757-0→. doi: 10.1016/j.wneu.2022.12.052→. PMID: 36529434→. Review, Meta-analysis˰ ˍ